145 related articles for article (PubMed ID: 11589765)
1. Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases.
Sumida Y; Nakashima T; Yoh T; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Okanoue T; Nakamura H; Yodoi J
Liver; 2001 Oct; 21(5):295-9. PubMed ID: 11589765
[TBL] [Abstract][Full Text] [Related]
2. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection.
Sumida Y; Nakashima T; Yoh T; Nakajima Y; Ishikawa H; Mitsuyoshi H; Sakamoto Y; Okanoue T; Kashima K; Nakamura H; Yodoi J
J Hepatol; 2000 Oct; 33(4):616-22. PubMed ID: 11059866
[TBL] [Abstract][Full Text] [Related]
3. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection.
Kato A; Odamaki M; Nakamura H; Yodoi J; Hishida A
Kidney Int; 2003 Jun; 63(6):2262-8. PubMed ID: 12753316
[TBL] [Abstract][Full Text] [Related]
4. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease.
Sumida Y; Nakashima T; Yoh T; Furutani M; Hirohama A; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Okanoue T; Kashima K; Nakamura H; Yodoi J
J Hepatol; 2003 Jan; 38(1):32-8. PubMed ID: 12480557
[TBL] [Abstract][Full Text] [Related]
5. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
[TBL] [Abstract][Full Text] [Related]
7. Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease.
Lee SH; Jeong SH; Park YS; Hwang JH; Kim JW; Kim N; Lee DH
Korean J Hepatol; 2010 Sep; 16(3):288-94. PubMed ID: 20924211
[TBL] [Abstract][Full Text] [Related]
8. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
9. Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.
Hamano K; Seo Y; Kato H; Kato M; Yano Y; Ninomiya T; Kasuga M
Int J Mol Med; 2006 Jun; 17(6):989-95. PubMed ID: 16685406
[TBL] [Abstract][Full Text] [Related]
10. Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C.
Mahmood S; Yamada G; Niiyama G; Kawanaka M; Togawa K; Sho M; Ito T; Sasagawa T; Okita M; Nakamura H; Yodoi J
Free Radic Res; 2003 Jul; 37(7):781-5. PubMed ID: 12911275
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis.
Jikimoto T; Nishikubo Y; Koshiba M; Kanagawa S; Morinobu S; Morinobu A; Saura R; Mizuno K; Kondo S; Toyokuni S; Nakamura H; Yodoi J; Kumagai S
Mol Immunol; 2002 Feb; 38(10):765-72. PubMed ID: 11841836
[TBL] [Abstract][Full Text] [Related]
12. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases.
Bell H; Skinningsrud A; Raknerud N; Try K
J Intern Med; 1994 Sep; 236(3):315-22. PubMed ID: 8077889
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid.
Nakashima T; Sumida Y; Yoh T; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Kashima K; Nakamura H; Yodoi J
Antioxid Redox Signal; 2000; 2(4):687-94. PubMed ID: 11213474
[TBL] [Abstract][Full Text] [Related]
14. Iron and proinflammatory cytokines in chronic hepatitis C virus infection.
López-Prieto J; González-Reimers E; Alemán-Valls MR; de la Vega-Prieto MJ; Abreu-González P; Pelazas-González R; Hernández-Luis R; Jorge-Ripper C; Santolaria-Fernández F
Biol Trace Elem Res; 2013 Oct; 155(1):5-10. PubMed ID: 23892696
[TBL] [Abstract][Full Text] [Related]
15. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes.
Lee DH; Zacharski LR; Jacobs DR
Am Heart J; 2006 Jun; 151(6):1247.e1-7. PubMed ID: 16781229
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum level of thioredoxin in patients with hepatocellular carcinoma.
Miyazaki K; Noda N; Okada S; Hagiwara Y; Miyata M; Sakurabayashi I; Yamaguchi N; Sugimura T; Terada M; Wakasugi H
Biotherapy; 1998; 11(4):277-88. PubMed ID: 9950104
[TBL] [Abstract][Full Text] [Related]
18. Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation.
Harrison P; Neilson JR; Marwah SS; Madden L; Bareford D; Milligan DW
J Clin Pathol; 1996 Oct; 49(10):853-6. PubMed ID: 8943756
[TBL] [Abstract][Full Text] [Related]
19. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).
Madan K; Bhardwaj P; Thareja S; Gupta SD; Saraya A
J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114
[TBL] [Abstract][Full Text] [Related]
20. [Effect of body iron stores in the indicators of alcohol abuse and alcoholic liver injury].
Cylwik B; Daniluk M; Chrostek L; Szmitkowski M
Pol Merkur Lekarski; 2010 Jun; 28(168):450-3. PubMed ID: 20642102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
